Volume 73, Issue 12 , Pages 623-627, December 2010
Fatigue in Colchicine Myopathy: A Study of Transcranial Magnetic Stimulation
Article Outline
Background
Transcranial magnetic stimulation (TMS) is a noninvasive method to assess brain physiology and plasticity. TMS has shown that nervous system excitability may be altered in myopathy, and it presents with motor disinhibition on cortical and subcortical levels. Eight patients who had colchicine myopathy were observed to have fatigue, but they did not have significant weakness. This study investigated whether there was central reorganization to compensate for their muscle strength.
Methods
TMS was applied to study the central compensative mechanism. The TMS parameters included motor evoked potentials, central conduction time, cortical silent period and intracortical inhibition of paired TMS paradigms.
Results
TMS results did not show any significant differences between patient and control groups.
Conclusion
Although central reorganization may occur in patients with hereditary myopathy to compensate for muscular strength, our study did not find any change in cortical excitabilities in acquired myopathy due to colchicine. Muscle fatigue may precede weakness as an early symptom of myopathy.
Key Words: colchicine , fatigue , myopathy , plasticity , transcranial magnetic stimulation
No full text is available. To read the body of this article, please view the PDF online.
References
- . Measurement of human muscle fatigue . J Neurosci Methods . 1997;74:219–227
- . Fatigue in neurological disorders . Lancet . 2004;363:978–988
- . Spinal and supraspinal factors in human muscle fatigue . Physiol Rev . 2001;81:1725–1789
- . Central and peripheral contributions to muscle fatigue in humans during sustained maximal effort . Eur J Appl Physiol Occup Physiol . 1999;80:57–63
- . Relative contributions of central and peripheral factors to fatigue during a maximal sustained effort . Eur J Appl Physiol . 2003;90:562–568
- . Fatigue after stroke: a major but neglected issue . Cerebrovasc Dis . 2001;12:75–81
- . Fatigue in multiple sclerosis: definition, pathophysi-ology and treatment . CNS Drugs . 2003;17:225–234
- Impact of fatigue on quality of life in patients with Parkinson's disease . Eur J Neurol . 2008;15:475–480
- . Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases . J Peripher Nerv Syst . 2005;10:329–337
- . Fatigue in myasthenia gravis patients . J Neurosci Nurs . 2003;35:87–93
- . Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I . J Neurol Neurosurg Psychiatry . 2005;76:1406–1409
- . Motor excitability in myopathy . Clin Neurophysiol . 2004;115:85–89
- Transcranial magnetic stimulation in patients with transient ischemic attacks . J Chin Med Assoc . 2004;67:229–234
- . The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus . Arch Neurol . 1989;46:1121–1123
- . Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group . Neurology . 1999;53:1648–1654
- Corticocortical inhibition in human motor cortex . J Physiol . 1993;471:501–519
- . The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group . Ann Intern Med . 1994;121:953–959
- Changes in motor cortex excitability in facioscapulohumeral muscular dystrophy . Neuromuscul Disord . 2004;14:39–45
- . Cortical excitability in Duchenne muscular dystrophy . Clin Neurophysiol . 2008;119:459–465
- Functional involvement of cerebral cortex in Duchenne muscular dystrophy . Muscle Nerve . 1998;21:662–664
- Somatosensory evoked potential recovery in myotonic dystrophy . Clin Neurophysiol . 2001;112:793–799
PII: S1726-4901(10)70136-2
doi:10.1016/S1726-4901(10)70136-2
© 2010 Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 73, Issue 12 , Pages 623-627, December 2010
